Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived...

Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells


Gonzalez et al. (2009)

Click here to read the full article


This study examined the treatment of RA in mice through administration of human adipose derived mesenchymal stem cell (hAdMSC’s) therapy. The results were promising, with prevention of disease progression by inducing the emergence of antigen specific Treg-cells, a subpopulation of T-cells that assist in preventing autoimmune diseases such as RA.


Recent Posts

See All

Contact Surecell Australia

Email: info@surecell.com

Phone: 03 9822 9996

Patient Enquiry

Patient Resources

Educational Videos

Training

© 2021 by Surecell Clinic. All Rights Reserved.

  • Grey Facebook Icon
  • Grey YouTube Icon
  • Grey LinkedIn Icon